The Latest Cardiac and Vascular News
IDE Approval Clears Path to U.S. Clinical Trial Launch for Vascular Sealant PARIS–(BUSINESS WIRE)–TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has received approval from the U.S. Food and Drug Administration for its Investigational Device Exemption application for its vascular sealant. The approval […]
MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today reported financial results for the third quarter 2020 and provided a business update. Tenax will share updates related to levosimendan and its recently completed Phase 2 […]
Preclinical CRO will enhance its pharmacology research services and reinforce its commercial offering to address the growing needs of the cardiovascular and safety markets Lautrec, France November 17, 2020 – PhysioStim, a preclinical CRO specialized in cardiac electrophysiology, today announces the appointment of Dr. Bruno Le Grand as scientific advisor. Dr. […]
OAKLAND, Calif.–(BUSINESS WIRE)–Dascena, Inc., a machine learning diagnostic algorithm company that is targeting early disease intervention to improve patient care outcomes, today announced that a poster highlighting the ability of a Dascena machine learning algorithm to predict acute heart failure (AHF) risk in patients is being presented during the American […]
Canon Medical’s AiCE Challenge Results Demonstrate Value of 1.5T MR with AI-Based Deep Learning Reconstruction (DLR) TUSTIN, Calif.–(BUSINESS WIRE)–The powerful Vantage Orian 1.5T MR with Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR) technology from Canon Medical Systems USA, Inc. delivers high-quality images with high signal-to-noise ratio* — an idea that is put […]
NILEMDO®▼ (bempedoic acid) is a new, first-in-class, oral, once-daily treatment which lowers Low-Density Lipoprotein Cholesterol (LDL-C) and can be combined with other treatments to help lower cholesterol even further1 Bempedoic acid acts on the well-known cholesterol synthesis pathway, upstream of the statin target in the liver, which allows additional LDL-C lowering […]
Silence Therapeutics Presents Positive Pre-Clinical Data for SLN360 for the Treatment of Elevated Lipoprotein(a) at American Heart Association 2020 Pre-clinical safety data show no adverse or off-target effects and targeted biodistribution of the company’s wholly owned gene-silencing candidate SLN360 Profile supports SLN360’s progression to in-human testing for the treatment of […]
XPLORER-HCM Cardiac Imaging Data Presented at AHA 2020 Scientific Session with Simultaneous Publication in Circulation Mavacamten Treatment Resulted in Favorable Effect on Cardiac Structure — Significantly Reduced Hypertrophy in Patients with Hypertrophic Cardiomyopathy BRISBANE, Calif., Nov. 15, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK) announced results from its cardiac magnetic resonance imaging (CMR) substudy of mavacamten for […]
Three-Year Study Results Presented at 2020 American Heart Association Scientific Sessions Zio Supports Better Healthcare Utilization Rates and Patient Outcomes With Ambulatory Cardiac Monitoring SAN FRANCISCO, Nov. 16, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, […]
WARRINGTON, Pa., Nov. 16, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today reported financial results for the third quarter ended September 30, 2020 and provided key business updates. Key Business and Financial Updates Announced the dosing […]
